Basic Information
LncRNA/CircRNA Name | CYTOR |
Synonyms | LINC00152 |
Region | GRCh38_2:87454781-87636740 |
Ensemble | ENSG00000222041 |
Refseq | NR_024204 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. |
Sample | NSCLC tumoral tissue, Normal bronchial epithelial cells 16HBE and human NSCLC cell lines including A549, 95D, H358, H1299, and H1581 |
Expression Pattern | up-regulated |
Function Description | CYTOR overexpression is a characteristic molecular change in NSCLC. CYTOR promoted cell proliferation, migration and invasion ability, and induced radioresistance in NSCLC cells. Mechanistically, CYTOR could directly interact with miR-195 and increase its targets. Thus, CYTOR played an oncogenic role in NSCLC progression through sponging miR-195. |
Pubmed ID | 30487160 |
Year | 2018 |
Title | Long noncoding RNA CYTOR Sponges miR-195 to Modulate Proliferation, Migration, Invasion and Radiosensitivity in Non-Small Cell Lung Cancer Cells |
External Links
Links for CYTOR | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |